Literature DB >> 19840675

WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008.

Rick A Bright1, Kathleen M Neuzil, Yuri Pervikov, Laszlo Palkonyay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19840675     DOI： 10.1016/j.vaccine.2009.02.084

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  12 in total

1.  Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.

Authors:  Caroline Gravel; Changgui Li; Junzhi Wang; Anwar M Hashem; Bozena Jaentschke; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  J Vis Exp       Date:  2011-04-04       Impact factor: 1.355

2.  Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.

Authors:  Maria I Solano; Adrian R Woolfitt; Tracie L Williams; Carrie L Pierce; Larisa V Gubareva; Vasiliy Mishin; John R Barr
Journal:  Anal Chem       Date:  2017-02-21       Impact factor: 6.986

Review 3.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

4.  Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.

Authors:  Marie-Clotilde Bernard; Joanna Waldock; Sylvie Commandeur; Lea Strauß; Claudia Maria Trombetta; Serena Marchi; Fan Zhou; Serge van de Witte; Peter van Amsterdam; Sammy Ho; Katja Hoschler; Vladimir Lugovtsev; Jerry P Weir; Emanuele Montomoli; Rebecca J Cox; Othmar G Engelhardt; Damien Friel; Ralf Wagner; Thierry Ollinger; Sophie Germain; Hanna Sediri-Schön
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

Authors:  Chia-Ying Wu; Yi-Chun Yeh; Jia-Tsrong Chan; Yu-Chih Yang; Ji-Rong Yang; Ming-Tsan Liu; Ho-Sheng Wu; Pei-Wen Hsiao
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

Review 6.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

Review 7.  In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.

Authors:  Teddy John Wohlbold; Florian Krammer
Journal:  Viruses       Date:  2014-06-23       Impact factor: 5.048

8.  Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.

Authors:  Don Changsom; Hatairat Lerdsamran; Witthawat Wiriyarat; Warunya Chakritbudsabong; Bunpote Siridechadilok; Jarunee Prasertsopon; Pirom Noisumdaeng; Wanibtisam Masamae; Pilaipan Puthavathana
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

9.  Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.

Authors:  Kangwei Xu; Changgui Li; Caroline Gravel; Zheng Jiang; Bozena Jaentschke; Gary Van Domselaar; Xuguang Li; Junzhi Wang
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

10.  Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.

Authors:  Melkamu Getie-Kebtie; Ishrat Sultana; Maryna Eichelberger; Michail Alterman
Journal:  Influenza Other Respir Viruses       Date:  2012-09-03       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.